NewsBenzingaDaré Bioscience Says It Received Nasdaq Minimum Bid Price Deficiency Notice, Has Until March 29, 2027 To Regain Compliance Daré Bioscience Says It Received Nasdaq Minimum Bid Price Deficiency Notice, Has Until March 29, 2027 To Regain Compliance Benzinga 2026.10.02 20:05 (GMT+0) Open on Benzinga Other news If You Invested $100 In Oracle Stock 20 Years Ago, You Would Have This Much Today Nike vs. Starbucks: One Beaten-Down Icon Is Primed for an Explosive Rebound Dividend Champion, Contender, And Challenger Highlights: Week October 4 If You Invested $100 In Flowserve Stock 5 Years Ago, You Would Have This Much Today Applied Digital: From Sell To Hold Ahead Of A High-Stakes Quarter (NASDAQ:APLD) Nvidia: Competition Caps The Upside Case (NASDAQ:NVDA)
